Derrick Sung Joins Aerin Medical as Chief Financial Officer

Aerin Medical Inc. has welcomed Derrick Sung as chief financial officer (CFO). Sung brings more than 25 years of finance, capital markets, and strategy experience across diverse roles within the medical device industry.
 
“It is with great pleasure that we welcome Derrick as the latest addition to our leadership team,” Aerin Medical CEO Matt Brokaw said. “With a proven track record of financial leadership and a wealth of operating expertise, Derrick will play a pivotal role in accelerating our pursuit of a new standard of care for millions of untreated sufferers of ENT conditions.”
 
Prior to joining Aerin Medical, Sung was CFO at Pulmonx Corporation, where he scaled the finance organization and led the company through significant growth and a successful IPO. Before that, he led strategy and corporate development at iRhythm Technologies. Previously, Sung spent seven years on Wall Street as a senior equity research analyst covering the medical devices sector, directed marketing and business development for Boston Scientific’s Neuromodulation division, led management consulting engagements at the Boston Consulting Group, and designed heart catheters as an R&D engineer for Guidant Corporation.

Sung earned his Ph.D. in bioengineering from the University of California, San Diego, his MBA from San Diego State University, and his bachelor of science degree in mechanical engineering from Stanford University.
 
“I am excited to join the team at Aerin Medical as we embark on the next phase of growth,” Sung stated. “Fueled by compelling fundamentals and a rare financial profile, we are poised to achieve remarkable success.”
 
Aerin Medical is a privately held, venture-backed company, with U.S. offices in California and Texas. Aerin’s mission is to expand access to relief from chronic ENT conditions. The company’s products, VivAer for nasal airway obstruction and RhinAer for chronic rhinitis, leverage Aerin’s proprietary temperature-controlled technology, which allows ear, nose, and throat physicians to reliably improve patients’ symptoms with unique technologies that are appealing alternatives to invasive surgery. More than 100,000 patients have been treated with Aerin Medical products to date.